This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Boehringer Ingelheim Vetmedica Gmbh. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovations of Hans-Jurgen Kroff
Introduction
Hans-Jurgen Kroff is a notable inventor based in Schoeneberg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of meloxicam solutions. His work has implications for both oral and parenteral administration, showcasing his expertise in medicinal chemistry.
Latest Patents
Kroff holds a patent for "Highly concentrated stable meloxicam solutions." This invention describes an aqueous cyclodextrin-free solution of meloxicam, which contains a pharmacologically acceptable meloxicam salt of an organic or inorganic base along with suitable excipients. The formulation boasts a high concentration of dissolved meloxicam salt, exceeding 10 mg/mL, and has a shelf-life of up to 24 months or more.
Career Highlights
Hans-Jurgen Kroff is associated with Boehringer Ingelheim Vetmedica GmbH, where he has contributed to various innovative projects. His work in developing stable pharmaceutical formulations has been instrumental in advancing veterinary medicine.
Collaborations
Kroff has collaborated with esteemed colleagues such as Stefan Henke and Bernd Kruss. Their combined expertise has fostered a productive environment for innovation within their field.
Conclusion
Hans-Jurgen Kroff's contributions to pharmaceutical formulations, particularly in meloxicam solutions, highlight his role as a significant inventor in the industry. His work continues to influence the development of effective medicinal products.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile